Celltrion Pharm Stock Market Capitalization
| 068760 Stock | KRW 52,700 300.00 0.57% |
Celltrion Pharm fundamentals help investors to digest information that contributes to Celltrion Pharm's financial success or failures. It also enables traders to predict the movement of Celltrion Stock. The fundamental analysis module provides a way to measure Celltrion Pharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celltrion Pharm stock.
Celltrion |
Celltrion Pharm Company Market Capitalization Analysis
Celltrion Pharm's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Celltrion Pharm Market Capitalization | 2.1 T |
Most of Celltrion Pharm's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celltrion Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Celltrion Pharm is about 2.1 T. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The market capitalization for all Republic of Korea stocks is notably lower than that of the firm.
Celltrion Pharm is number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is presently estimated at about 4.21 Trillion. Celltrion Pharm totals roughly 2.1 Trillion in market capitalization claiming about 50% of equities under Health Care industry.Celltrion Fundamentals
| Return On Equity | 0.0891 | |||
| Return On Asset | 0.0341 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 5.87 T | |||
| Shares Outstanding | 34.05 M | |||
| Shares Owned By Insiders | 57.79 % | |||
| Shares Owned By Institutions | 6.75 % | |||
| Price To Earning | 62.82 X | |||
| Price To Sales | 8.22 X | |||
| Revenue | 398.74 B | |||
| Gross Profit | 72.93 B | |||
| EBITDA | 42.8 B | |||
| Net Income | 34.58 B | |||
| Cash And Equivalents | 80.19 B | |||
| Cash Per Share | 815.33 X | |||
| Total Debt | 39.4 B | |||
| Debt To Equity | 0.64 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 10,914 X | |||
| Cash Flow From Operations | 93.15 B | |||
| Target Price | 136000.0 | |||
| Number Of Employees | 29 | |||
| Beta | 0.23 | |||
| Market Capitalization | 2.1 T | |||
| Total Asset | 637.88 B | |||
| Retained Earnings | 30.6 B | |||
| Working Capital | 58.94 B | |||
| Current Asset | 144.21 B | |||
| Current Liabilities | 85.27 B | |||
| Z Score | 31.8 | |||
| Net Asset | 637.88 B |
About Celltrion Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celltrion Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celltrion Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celltrion Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Celltrion Stock
Celltrion Pharm financial ratios help investors to determine whether Celltrion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celltrion with respect to the benefits of owning Celltrion Pharm security.